 Name: ___         Unit No:  ___  Admission Date: ___       Discharge Date:  ___  Date of Birth: ___       Sex:  M  Service: MEDICINE  Allergies: nitroglycerin / Tylenol / Chantix  Attending: ___.  Chief Complaint: shortness of breath, productive cough  Major Surgical or Invasive Procedure: Bronchoscopy and endobronchial ultrasound with fine needle aspiration

 History of Present Illness: ___ with > 120 py smoking history, oropharyngeal squamous cell carcinoma s/p chemo-radiation ___ ___ and placement of PEG tube (___) for nutrition presenting with dyspnea. Gets care mostly at ___ , but thoracic surgery f/u @ ___. Seen on ___ for evaluation of a FDG-avid 8mm right upper lobe lung nodule, concerning for either primary lung cancer or metastatic disease. Seen again on ___, when he had a CPET ___ (pt cancelled prior appts for rib pain after a fall)  notable for 74% predicted VO2 (average surgical risk). Follow up CT scan in ___ at ___ notable for increase in size of the RUL nodule to 11mm, the development of two additional nodules (18mm and 13mm), and mediastinal and right hilar lymphadenopathy.  Now he presented to OSH ED for evaluation of subjective SOB on exercion, CT PE was done - notable for negative PE but significantly narrowed RUL takeoff, worsening hilar lymphadenopathy with post-obstructive component. Transferred to ___ and IP consulted.  In the ED, initial vitals were: 97.1 88 113/77 18 97% RA  - Labs were significant for INR 6.5.  - The patient was given oxycodone 60mg and 1L NS.  Vitals prior to transfer were: 98 84 116/80 18 95% RA  Upon arrival to the floor, denies SOB, CP. Reports that he has been eating for ___ months and has not needed PEG tube. Reports 2d of cough, with no fever, chills. Cough has been intermittent and productive of whitish sputum.   Past Medical History: PAST MEDICAL & SURGICAL HISTORY:  - oropharyngeal squamous cell carcinoma s/p chemo-radiation ___  ___ ___  - HTN  - MI ___  - Hyperthyroidism  - Hyperlipidemia  - CAD  - Hx of ETOH abuse  PAST SURGICAL HISTORY:  - placement of PEG tube ___  - Suspension Microlaryngoscopy with biopsy (___)  - Tonsillectomy  - bilateral eyelid surgery  - cardiac stents x2 (___)  - CABG (___) 

 Social History: ___ Family History: none  Physical Exam: ADMISSION:

Vitals: 97.9 128/68 86 18 100RA  General: Alert, oriented, no acute distress  HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  Neck: Supple, JVP not elevated, no LAD  CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops  Lungs: upper airways sounds on upper half b/l, more prominent on R side, no focal absent lung sounds  Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding, PEG tube in place  Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema  Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred. 

DISCHARGE:

Vitals: Tc 97.9 Tm 98.3 HR ___, BP 100-110s/50-60s, RR 18 SpO2 100% RA General: thin, bi-temporal wasting, alert, oriented, no acute distress  HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRLA.  Neck: Supple, JVP not elevated, no LAD  CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops  Lungs: rhoncherous BS on R side, no focal absent lung sounds Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding, PEG tube in place  Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema  Neuro: grossly normal motor and sensation.

 Pertinent Results: ADMISSION ===================

___ 09:20PM BLOOD WBC-7.8 RBC-3.63* Hgb-11.6* Hct-33.8* MCV-93 MCH-32.0 MCHC-34.3 RDW-14.1 RDWSD-47.7* Plt ___ ___ 09:20PM BLOOD Neuts-79.1* Lymphs-6.4* Monos-13.0 Eos-0.0* Baso-0.3 Im ___ AbsNeut-6.19* AbsLymp-0.50* AbsMono-1.02* AbsEos-0.00* AbsBaso-0.02 ___ 09:20PM BLOOD Glucose-120* UreaN-12 Creat-0.7 Na-137 K-3.8 Cl-96 HCO3-25 AnGap-20 ___ 06:00AM BLOOD Calcium-8.3* Phos-3.0 Mg-1.8 ___ 09:43PM BLOOD Lactate-3.8*

PERTINENT RESULTS ===================

___ 09:43PM BLOOD Lactate-3.8* ___ 09:16AM BLOOD Lactate-1.8 ___ 06:08PM BLOOD ___ pO2-111* pCO2-56* pH-7.28* calTCO2-27 Base XS--1 Comment-PERIPHERAL

IMAGING =================== ___ CXR No comparison. Isolated right upper lobe parenchymal opacities, combined to pleural thickening and enlargement of the right hilus. The changes are characterized in substantially more detailed on the CT examination from ___. Normal appearance of the cardiac silhouette. Mild elongation of the descending aorta. 

MICROBIOLOGY ===================

___ 3:05 pm SPUTUM   Source: Expectorated. 

              **FINAL REPORT ___

  GRAM STAIN (Final ___:    <10 PMNs and >10 epithelial cells/100X field.    Gram stain indicates extensive contamination with upper respiratory    secretions. Bacterial culture results are invalid.    PLEASE SUBMIT ANOTHER SPECIMEN. 

  RESPIRATORY CULTURE (Final ___:    TEST CANCELLED, PATIENT CREDITED. 

___ 9:20 pm BLOOD CULTURE

              **FINAL REPORT ___

  Blood Culture, Routine (Final ___:  NO GROWTH. 

PATHOLOGY ================== FNA from EBUS ___ - pending

DISCHARGE LABS ===================

___ 06:05AM BLOOD WBC-6.8 RBC-3.26* Hgb-10.1* Hct-31.8* MCV-98 MCH-31.0 MCHC-31.8* RDW-14.3 RDWSD-50.2* Plt ___ ___ 06:05AM BLOOD ___ PTT-33.9 ___ ___ 06:05AM BLOOD Glucose-97 UreaN-16 Creat-0.7 Na-137 K-4.2 Cl-96 HCO3-27 AnGap-18 ___ 06:05AM BLOOD Calcium-9.0 Phos-3.4 Mg-1.8

 Brief Hospital Course: SUMMARY: ___ with > 120 py smoking history, oropharyngeal squamous cell carcinoma s/p chemo-radiation ___ ___ and placement of PEG tube (___), recently diagnosed lung mass presenting with dyspnea. He was treated with levofloxacin and clindamycin for post-obstructive pneumonia. He was clinically stable throughout hospitalization without oxygen requirement. He was maintained on his home pain medications only and was discharged on lower dose due to sedation. He underwent bronchoscopy with fine needle biopsy. 

 # R bronchus obstruction: Pt presented with dyspnea to OSH and found to have R bronchus obstruction from mass. Pt actually currently comfortable with no SOB, satting in upper ___, and no significant cough. No fever, significant cough, leukocytosis to warrant abx currently for presumed PNA. S/P bronch on ___ w/ dilation, pus visualized, multiple biopsies. Will complete a 10 day course of levofloxacin/flagyl. Outpatient oncology follow-up arranged.

 # oropharyngeal squamous cell carcinoma s/p chemo-radiation ___ ___ and placement of PEG tube: Unclear if new lung nodules are pimary lung cancer vs recurrence/metastasis of oropharyngeal SCC. Patient unclear of plan fo further management. Pt has not been using PEG tube for 2 months. Patient has outpatient f/u with ENT, oncology previously arranged and now sooner.

 # Afib: amiodarone and warfarin and diagnosis of afib in outpatient cardiology notes. NSR on ECG, rhythm control with amio. Continued home beta ___, amiodarone. Held coumadin prior to bronch with biopsy. Conservatively restarted prior to discharge with patient to f/u with PCP ___ ___.

 # CAD: continued home atorvastatin, ___, metoprolol 

TRANSITIONAL ISSUES: - Last day of antibiotics = ___ for two weeks course following bronchoscopy - Patient underwent fine needle aspiration of endobronchial lesion. Oncologist, Dr. ___ will need records regarding biopsy results. - patient on oxycodone 60 mq Q6 hrs at home, discharged on decreased dose. Consider continued down titration given high dose. - CODE STATUS: FULL - CONTACT: Wife, ___  ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Warfarin 3 mg PO DAILY16 2. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB 3. Amiodarone 200 mg PO DAILY 4. carisoprodol 350 mg oral TID 5. Pantoprazole 40 mg PO Q24H 6. OxycoDONE (Immediate Release) 60 mg PO Q6H:PRN pain 7. pilocarpine HCl 5 mg oral TID 8. Aspirin 81 mg PO DAILY 

 Discharge Medications: 1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB 2. Amiodarone 200 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. carisoprodol 350 mg oral TID 5. Pantoprazole 40 mg PO Q24H 6. pilocarpine HCl 5 mg oral TID 7. Atorvastatin 10 mg PO QPM RX *atorvastatin 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 8. Metoprolol Succinate XL 25 mg PO DAILY RX *metoprolol succinate 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 9. Levofloxacin 750 mg PO DAILY RX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*9 Tablet Refills:*0 10. Outpatient Lab Work Atrial fibrillation ICD 10 148.91 Labs drawn for INR on ___ faxed to: Name: ___. Phone: ___ Fax: ___ 

11. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H RX *metronidazole 500 mg 1 tablet(s) by mouth every 8 hours Disp #*30 Tablet Refills:*0 12. Warfarin 2.5 mg PO DAILY16 RX *warfarin 2.5 mg 1 tablet(s) by mouth daily Disp #*15 Tablet Refills:*0 13. OxycoDONE (Immediate Release) 30 mg PO Q4H:PRN pain RX *oxycodone 30 mg 1 tablet(s) by mouth every four hours Disp #*36 Tablet Refills:*0

 Discharge Disposition: Home  Discharge Diagnosis: PRIMARY: Post-obstructive pneumonia

SECONDARY: Oropharyngeal squamous cell carcinoma Atrial fibrillation

 Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent.

 Discharge Instructions: Dear Mr. ___,

It was a pleasure caring for you at the ___ ___. You were recently admitted for shortness of breath and productive cough, likely caused by a pneumonia due to a lung mass. You were treated with medications prior to undergoing biopsy of this lesion with via bronchoscopy. You were treated with antibiotics and improved and will continue to take these medications at home. In order to expedite your follow-up, you will see Dr. ___ of Dr. ___ your oncology follow-up. This appointment has been arranged for you already.

Please continue to take all of your medications as prescribed and keep all of your follow-up appointments. OF note, you will be on two antibiotics with the last day being ___. See Dr. ___ new oncologist on ___ at 9am. See Dr. ___, ___ primary care doctor at 2:30pm on ___. See Dr. ___, ___ ear/nose/throat specialist on ___ at 2:15pm.

It was a pleasure taking part in your care.

Sincerely, Your ___ Care Team  Followup Instructions: ___ 